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Background: During the COVID-19 pandemic increased risk of poor mental health 
has been evident across different cultures and contexts. This study aims to examine 
whether allostatic load (AL) prior to the pandemic was predictive of poor mental 
health during the pandemic, and if any associations were moderated by neuroticism. 
Methods: Data were extracted from Waves 2 (2011, allostatic load), 3 (2012, 
neuroticism), and the COVID-19 study (April 2020) of the Understanding Society 
database in the UK; data were available for 956 participants. Results: Mental health 
increased from 2012- to during the pandemic. Neuroticism and AL were positively 
associated with poorer mental health during COVID-19, such that those who had 
scored higher on neuroticism and had higher AL prior to the pandemic reported 
poorer mental health during the pandemic. Neuroticism was also a significant 
moderator; the effect of AL on mental health during the pandemic was exacerbated in 
those with high and moderate levels of neuroticism but not lower. Moreover, this was 
driven by the immune-related indices of AL. This withstood adjustment for age, 
gender, employment status and prior mental health. These findings are discussed in 
relation to the pathophysiological mechanisms of mental health. 
 











1. Introduction        
      The negative impact of the COVID-19 pandemic on mental health in a variety of 
populations has already been noted (Gallagher, Bennett, & Roper, 2020; Gallagher & 
Wetherell, 2020) and is now well-established (Vindegaard & Benros, 2020). The 
theory of ‘allostatic load’ (AL) has been proposed as a model of understanding the 
physical and mental health consequences of dealing with the prolonged stress, and 
may well be an important health indicator pursuant to the unique stressors arising 
from COVID-19 pandemic (Theorell, 2020).  This theory posits that repeated or 
inadequate physiological adaption to stress over time results in wear and tear on the 
body, which mediated through the dysregulation of glucocorticoids via the 
hypothalamic-pituitary-adrenal (HPA) axis and catecholamine via the sympathetic 
nervous system (SNS), will result in dysfunction of the cardiovascular, immune, and 
metabolic systems (McEwen, 1998, 2005), thereby leading to ill-health. AL confers 
significant physical health decrements for those that experience it; however it may 
also constitute a precipitative factor for mental health outcomes longitudinally (Juster 
et al., 2011). Longitudinal assessments of AL also indicate that accumulating 
stressors can worsen levels of AL, thereby worsening the overall impact to both 
physical and mental health over time (Piazza, Stawski, & Sheffler, 2019). Taken 
together, this suggests that the accumulation of stress to the point of AL does not end 
there, and that future stressful experiences, such as the COVID19 pandemic, continue 
to contribute to AL, and that these impacts also contribute to the manifestation of 
mental health conditions such as depression.  
      A recent study found that a psychological index of self-assessed AL (e.g., stress, 
well-being, psychological distress, abnormal illness and quality of life) was elevated 









study did not examine the underlying physiological indices of AL, other research 
suggests that there are likely inflammatory biomarkers associated with both COVID-
19 infection and mental health (Senra, 2021). In fact, a recent study found that in 
adult survivors of COVID-19, depression and anxiety symptoms at 1-month follow-
up were positively associated with baseline systemic inflammation (Mazza et al., 
2020); this is consistent with the notion that inflammation is a key pathophysiological 
mechanism underlying  mood disorders (Miller, Maletic, & Raison, 2009). Despite 
this, it is also likely that the effects of AL on mental health during COVID-19 are 
independent of infection/disease. Evidence for this idea comes from a recent 
systematic review highlighting that AL was predictive of mental health in both 
healthy and unhealthy populations (Guidi, Lucente, Sonino, & Fava, 2021); as such, it 
might be that AL prior to the pandemic is predictive of mental health outcomes 
during COVID-19.  
Therefore, the aim of the present study was to establish if AL prior to the 
pandemic was predictive of negative mental health during the pandemic. 
Furthermore, as neuroticism has previously been shown to be associated with AL  
(Stephan, Sutin, Luchetti, & Terracciano, 2016), as well as being predictive of poor 
mental health (Gale et al., 2016; Nikčević, Marino, Kolubinski, Leach, & Spada, 
2021), its role as a potential moderator was examined. Neuroticism is a stable 
personality trait reflecting the tendency to form negative appraisals of both immediate 
and long-term stressors (McCrae, 1990), including vulnerability to stress 
(O’Súilleabháin, Hughes, Oommen, Joshi, & Cunningham, 2019). According to the 
diathesis-stress model of psychopathology, an individual possesses some degree of 
inherent vulnerability (i.e., diathesis) for developing a given disorder (Broerman, 










(COVID-19). Thus, given that neuroticism is a highly stress-relevant personality trait 
that moderates physiological reactions to stress (Chida & Hamer, 2008; Hughes, 
Howard, James, & Higgins, 2011) its role in moderating any association between AL 
and mental health was examined. We predicted that 1) AL and neuroticism would 
independently predict poorer mental health during COVID-19; and 2) neuroticism 
would be a moderator of the association between AL prior to the pandemic and 




2.1 Participants  
      Our data was obtained from three waves of the Understanding Society study in the 
UK (Essex., 2010-12); Wave 2 (2011, biomarker study), Wave 3 (2012; personality 
measures), and COVID-19 first wave (April 2020; first UK lockdown). Participants 
are a stratified clustered random sample of households representative of the UK 
general population. The study has ethical approval and each participant gave 
informed consent prior to participation.   
      From Wave 2, we extracted AL variables, socio-demographic, and other health-
related information that would likely to confound observed relationships (e.g., use of 
any medication). We dichotomized several of our socio-demographic variables 
including relationship status (married/partnered vs single/divorced/widowed), 
education level (college education vs high school or less), and ethnicity 
(Caucasian/white vs other).  Given that use of medication is likely to indicate a health 
condition, along with influence on the immune and hormonal systems (Rhen & 










(except the contraceptive pill) and/or reported being pregnant were excluded.  
Participants were only included if they had detectable levels of biomarkers for 
assessment of AL, and completed the personality assessment at both Wave 2 and the 
COVID-19 study in April 2020. See Figure 1 for participant selection and Table 1 for 
socio-demographics characteristics). 
  
[Insert Figure 1 About Here] 
2.2 Measures         
2.2.1 Mental Health   
Mental health was captured by the 12-item General Health Questionnaire 
(GHQ)(Goldberg et al., 1997) at Wave 2 and during COVID-19.  Items (e.g., unhappy 
or depressed) are scored as 1= not at all; 2= no more than usual; 3= rather more than 
usual; 4= much more than usual.  The scale is a widely used scale, which has intrinsic 
value as an indicator of psychological distress, particularly in population studies such 
as this,(Lundin, Hallgren, Theobald, Hellgren, & Torgén, 2016).  The continuous 
scores are used here with higher scores indicate poorer mental health. Internal 
consistency was high, α = .91 for Wave 2 and during COVID-19 α = .90. 
 
2.2.2 Neuroticism  
This was captured by the 15-item questionnaire on the Five-Factor Model traits 
(Hahn, Gottschling, & Spinath, 2012); neuroticism was assessed with three questions 
coded on a 7-point scale, where 0 indicated “does not apply to me at all”, and 6 
indicated “applies to me perfectly”. The value range for each trait's total score was 0–











2.2.3 Allostatic Load 
      Blood samples for Wave 2 were collected during a single nurse visit, which took 
place in the participant's home 5 months after wave 2 interviews.  In line with the 
original definition (Seeman, McEwen, Rowe, & Singer, 2001), 12 biomarkers 
representing four biological systems were used in the measurement of AL: the 
neuroendocrine system (DHEA-s); the immune system (insulin-like growth factor-1 
[IGF1], C-reactive protein [CRP], and fibrinogen); the metabolic system (high-
density lipoprotein [HDL], low-density lipoprotein [LDL], glycosylated haemoglobin 
[HbA1C, albumin, waist circumference and body mass index [BMI]); and the 
cardiovascular system (systolic blood pressure [SBP], diastolic blood pressure 
[DBP]). These were dichotomized into risk (high vs low) according to quartiles scores 
or sex-specific risk (e.g., waist circumference), or established criteria (e.g., SBP/DBP 
> 140/90 and BMI > 25); for some indices (i.e., HDL cholesterol and DHEA-S), the 
lowest quartile corresponded with the highest risk (T. E. Seeman et al., 2001). As 
both high and low IFG1 levels have been predictive of morbidity and mortality 
(Mikkel et al., 2009; Sanders et al., 2018), these two quartiles served as high risk.  
The risk scores where then coded at 1= high risk and 0= low risk and summed with 
higher scores indicating higher degree of risk (Brody et al., 2014; Hawkley, Lavelle, 
Berntson, & Cacioppo, 2011;Seeman et al., 2004).   
 
2.3 Analytic Approach   
      Prior to hypothesis testing, data were screened for assumptions of fit and 
normality; all p’s for Kolmogorov-Smirnov and Shapiro- tests were >. 05. Following 
this, descriptives and correlations were used to examine correlations with our 










from our baseline (Wave 2) dataset. For our main analyses, we conducted hierarchal 
linear regressions with confound factors (age, gender, relationship status, and baseline 
mental health) entered at Step 1, and neuroticism and AL together in Step 2. For our 
moderation analysis, we used model 1 in Process (Hayes, 2017), to see whether the 
association between AL interacted with levels of neuroticism.  
Results 
3.1. Preliminary analyses  
     As can be seen from Table 1, the sample was middle-aged, predominantly White, 
mostly in a relationship, employed, and over half the sample did not have a 
University degree. Older participants had higher AL but better mental health during 
COVID-19.  Allostatic load was higher in men. Women and those who were not 
married/partnered had poorer mental health during the pandemic. Mental health at 
baseline (2011) and neuroticism were associated with poorer mental health during 
COVID-19.  These data are for baseline values. However, mental health increased 
from baseline to follow-up at the pandemic (t =54.55, p <.001). Given the significant 
associations above with our outcome variable, we controlled for age, gender, 
relationship status, and prior mental health (measured in wave 2) in our main 
analyses.  
 
2.3 Associations between neuroticism, AL and mental health during COVID-19  
      In regression analyses, after controlling for confounding in Step 1, both 
neuroticism, and allostatic load were associated with mental health during COVID-19 
9 (See Table 2).  Here those who scored higher on neuroticism and who had a higher 
AL had poorer mental health during the pandemic. The co-variates in Step 1 










neuroticism and AL added an additional 1.2% (delta (Δ). We re-ran this regression 
again looking at both immune and non-immune indices of AL as predictors to see if 
they offered any unique variance (Wiley, Gruenewald, Karlamangla, & Seeman, 
2016).  In this instance, both proved to be predictive: immune indices, β = .09, 95% 
CI [.052, .39], t = 2.55, p =.01; and non-immune indices, β = .08, 95% CI [.036, .29], 
t = 2.50, p =.01.   Following this sensitivity analysis, we checked to see if immune or 
non-immune indices predicted increased depressive symptoms from baseline to 
follow-up, i.e. change scores. In this analysis, it was the immune-related indices that 
were predictive β = .06, 95% CI [.02, .35], t = 1.98, p =.04, but not the non-immune, 
p = .16. Neuroticism was also a predictor in this instance, β = .10, 95% CI [.09, .38], t 
= 3.17, p =.02. 
[Insert Table 2 About Here] 
3.3. Moderation analyses  
      After controlling for confounding, the association between AL (total score) and 
mental health during COVID-19 was moderated by neuroticism, β = .08, 95% CI 
[.012, .152], t = 2.32, p =.02.  Further, analysis of conditional effects also indicated 
that the effect of AL on mental health was only significant for those at the medium 
(3.39), β = .11, 95% CI [ .016, .209], t = 2.17, p =.03, and higher (4.71), β = .21, 95% 
CI [.084, .354], t = 3.18, p =.001, levels of neuroticism, but not lower levels (2.07) , β 
= .001, 95% CI [-.135, .137], t = 0.015, p =.98.  Moreover, on re-running these 
analyses again we re-ran this moderation for both immune and non-immune indices 
for AL and the effects were only evident for immune-related indices of AL, β = .13, 
95% CI [.023, .233], t = 2.48, p =.01. 
 










      This is the first study to demonstrate that AL prior to the pandemic is a risk factor 
for poor mental health during COVID-19, with the association between AL and mental 
health moderated by neuroticism. Interestingly, this was only evident for the immune-
indices of AL (e.g., IGF1, CRP and fibrinogen). Other studies have also observed 
similar patterns, but instead of neuroticism moderating the effect of AL on mental 
health, it was general intelligence that interacted with CRP on mental health (Midouhas 
et al., 2018). Moreover, these effects withstood adjustment for several important 
confounders (e.g., age, gender, relationship status, and prior mental health).  
Our result for a direct association between AL and future mental health is 
consistent with the findings of a recent meta-analysis (Guidi et al., 2021). Interestingly 
in our correlation models (Table 1) AL was not correlated with mental health during the 
pandemic but after controlling for confounding it was. The effect for neuroticism is 
similar to that found elsewhere (Nikčević et al., 2021).  However, the observed 
moderation effect of AL on mental health via medium and high neuroticism is 
consistent with the diathesis stress model of psychopathology (Broerman, 2017) which 
suggests that individuals possess a vulnerability (i.e., poor coping skills in those high 
on neuroticism) combined with a biological vulnerability, for dealing with stressors 
which puts them at risk of poor mental health.  Here, we found this moderation was 
only evident for the immune indices, particularly markers of inflammation, and as such 
inflammation may be important for the stress-diathesis model. Moreover, our finding 
for immune-related indices is also in line with current thinking on the role of 
inflammation in the pathophysiology of mood and other psychiatric disorders (Miller, 
2020). 
While our study has several strengths (e.g., longitudinal design, population study 









other unmeasured factors that may be associated with poor mental health during 
COVID-19 (e.g., loneliness, job loss), and as such, there may be other interactions, as 
well as other personality traits, that heighten or mitigate the risk of poor mental health. 
Second, our mental health status was derived through a self-report scale rather than 
psychiatric interview. Nonetheless, we used a widely used scale, which has intrinsic 
value as an indicator of mental health (Hahn et al., 2012). Moreover, while it would 
have been more ideal AL was taken closer to the pandemic, it was taken approximately 
9-years earlier, it is similar to other recent testing similar interactions (Midouhas et al., 
2018), and in the present study offers a strength in identifying if AL has prognostic 
power. Further, the power of AL for predicting health outcomes was stronger for 10 
years but not at 5 years (Robertson, Beveridge, & Bromley, 2017). Further, while AL 
could remain stable when we encounter unpredictable events in our environments it can 
increase dramatically and become allostatic overload and damaging for health (B. S. 
McEwen, 2017). This could have been the case during the current pandemic and 
perhaps we may see evidence of this emerging in the near future.  Our COVID-19 
mental health assessment was conducted in the April 2020 wave. Although we 
anticipate that individuals high in AL might experience a decline in mental health 
regardless of COVID19, the onset of COVID19 has been established as a highly 
stressful context during which population mental health has been adversely affected 
(Mazza et al, 2020). The unique opportunity of this dataset also allowed us to test the 
diathesis model of psychopathology in which the stressor was present in combination 
with the psychological and biological vulnerability. Finally, the Understanding Society 
collects data on an ongoing basis over a 2-year period, there was the possibility of some 
overlap at the biomarker study and Wave 3 (neuroticism) assessment and this should 










test the diathesis stress model where exposure to a stressor is needed to test the model 
(Broerman, 2017) and the COVID-19 dataset allowed us to achieve this by combining 
all relevant factors.  
To conclude, this study confirmed that AL, specifically immune-related indices, is 
a key factor for predicting future mental health, even when assessed many years 
previous. In addition, the findings highlight how a stable personality trait such as 
neuroticism moderates this relationship. Together, the combination of higher 
neuroticism with higher AL lead to poorer mental health in the COVID-19 pandemic. 
This highlights that dysregulation across physiological systems, particularly immune-
related ones, along with stable tendency to perceive stress, puts individuals at increased 
risk of poor mental health during times of increased stress.  
        Funding: None  
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Figure 1. Participant selection flow diagram 
 
  
N = 10,175 Wave 2 blood study 
Of the above, N = 2,273 participated in April 2020 
 
Those not on medication Wave 2, N =1235 
Neuroticism at Wave 3, N = 1,168  
Those on medication had higher AL, p <.001; were higher on 
neuroticism, p =.032; had higher GHQ scores at baseline (p =.005)  
and during COVID-19, p =.002; they were older, p<.001; and were 
more likely to be women, p<.001.  
GHQ both waves; Neuroticism & AL = 956 










 Table 1. Participant socio-demographics and correlations among study variables    
Correlations are p <.05*; p <.01** 
  
 Mean (SD)/% Ranges 1 2 3 4 5 6 7 8 9 10 
1. Age 44.91 (13.54) 16-80  .08** -.25** .04 -.01 -.04 -.09* -.16** .27** -.12** 
2. Gender 47.1% female    .08** .03 -.04 .01 .06* .15** -.11* .17** 
3. Relationship status  59.2% married     .001 .14** .003 .04 .08* -.01 .12** 
4. Ethnicity  97.4% White      -.01 -.02 -.06* .02 -.03 -.01 
5. Education degree 45% Degree or higher        .05 .01 .01 .11** .02 
6. Employment  75.5% employed         -.03 .001 .002 .06 
7. Baseline GHQ  1.38 (2.58) 0-12        .45** -.09** .33** 
8. Neuroticism  3.45 (1.34) 1-7         .10** .23* 
9. Allostatic load 4.47 (1.63) 1-10          .03 











Table 2. Hierarchical linear regression with demographic, prior mental health, neuroticism and  
allostatic load predicting mental health during COVID-19   




Step 1      
Age  -.02 -0.65 .51 -0.19 0.009 
Gender  .19 5.89 .001 0.69 1.39 
Relationship status  .03 0.88 .37 -.19 0.54 
GHQ baseline .29 7.62 .001 0.14 0.22 
Step 2      
Neuroticism    .07 2.07 .038 0.008 0.29 
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